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Background:  Previous studies have established that subjects in the general population without overt heart failure (HF) in whom NT-proBNP is 
above age / gender adjusted 80th percentile values are at increased risk for HF. Importantly, NT-proBNP levels associated with increased risk are 
well below those values seen in HF and in general are within the reported normal ranges. In our goal to develop primary prevention strategies for HF 
we sought to in-depth phenotype subjects with increased risk of HF as defined by mild NT-proBNP elevations in the general population.
Methods:  We used a community-based cohort of 2,042 subjects from Olmsted County, MN. Plasma NT-proBNP, thorough echocardiographic and 
clinical data were recorded for all of the participants at the start of the study. Individuals with stage C/D HF at the start of the study were excluded. 
Age / gender specific 80th percentile values for NT-proBNP were defined. Median follow-up for development of HF was 9.1 years. *P<0.05
Results:  Seventy eight of the 386 subjects (21%) with an NT-proBNP > 80th percentile developed HF during the 9.1 years of follow-up, a higher 
percentile than subjects with an NT-proBNP below the 80th percentile*. Subjects who developed HF were older* and more likely to be male*, 
diabetic*, and hypertensive*. They also had greater prevalence of prior myocardial infarction* and coronary disease*. Importantly the presence of 
asymptomatic diastolic dysfunction*, LV hypertrophy*, LA enlargement*, and valvular dysfunction* was higher among subjects who developed HF.
Conclusions:  These findings suggest that high risk subjects in the general population without HF as identified by mild NT-proBNP elevation who 
develop HF during 9.1 years of follow-up have a significantly higher prevalence of asymptomatic structural abnormalities of the heart and clinical 
HF risk factors. Our results support a proof of concept study to use mild NT-proBNP elevations to identify high risk asymptomatic subjects, further 
evaluate with echocardiogram, and aggressively intervene for clinical risk factors and structural abnormalities identified.
